{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:14:48Z","timestamp":1791774888746,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52233013"],"award-info":[{"award-number":["52233013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52303208"],"award-info":[{"award-number":["52303208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22435006"],"award-info":[{"award-number":["22435006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["22435006"],"award-info":[{"award-number":["22435006"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011081","name":"\u00c9cole Nationale d'Ing\u00e9nieurs de Saint-Etienne","doi-asserted-by":"publisher","award":["223B2504"],"award-info":[{"award-number":["223B2504"]}],"id":[{"id":"10.13039\/501100011081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-025-00993-4","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:04:05Z","timestamp":1749531845000},"page":"1384-1399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-4671","authenticated-orcid":false,"given":"Jinpeng","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8579-6367","authenticated-orcid":false,"given":"Shenqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-7111","authenticated-orcid":false,"given":"Yinxian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5277-7338","authenticated-orcid":false,"given":"Ruikang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7564-6207","authenticated-orcid":false,"given":"Zhaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-4456","authenticated-orcid":false,"given":"Zhen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"993_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","volume":"7","author":"W Li","year":"2022","unstructured":"Li, W. et al. Clinical translation of long-acting drug delivery formulations. Nat. Rev. Mater. 7, 406\u2013420 (2022).","journal-title":"Nat. Rev. Mater."},{"key":"993_CR2","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41563-020-0674-z","volume":"19","author":"TA Kulkarni","year":"2020","unstructured":"Kulkarni, T. A. et al. A year-long extended release nanoformulated cabotegravir prodrug. Nat. Mater. 19, 910\u2013920 (2020).","journal-title":"Nat. Mater."},{"key":"993_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2020.01.020","volume":"320","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. Mechanism of a long-term controlled drug release system based on simple blended electrospun fibers. J. Control. Release 320, 337\u2013346 (2020).","journal-title":"J. Control. Release"},{"key":"993_CR4","doi-asserted-by":"publisher","first-page":"2308254","DOI":"10.1002\/adma.202308254","volume":"36","author":"Z Dong","year":"2024","unstructured":"Dong, Z. et al. Tumor microenvironment modulating CaCO3-based colloidosomal microreactors can generally reinforce cancer immunotherapy. Adv. Mater. 36, 2308254 (2024).","journal-title":"Adv. Mater."},{"key":"993_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","volume":"14","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat. Nanotechnol. 14, 89\u201397 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"993_CR6","doi-asserted-by":"publisher","first-page":"121880","DOI":"10.1016\/j.biomaterials.2022.121880","volume":"291","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy. Biomaterials 291, 121880 (2022).","journal-title":"Biomaterials"},{"key":"993_CR7","doi-asserted-by":"publisher","first-page":"1605903","DOI":"10.1002\/adma.201605903","volume":"29","author":"S Yao","year":"2017","unstructured":"Yao, S. et al. Biomineralization: from material tactics to biological strategy. Adv. Mater. 29, 1605903 (2017).","journal-title":"Adv. Mater."},{"key":"993_CR8","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1021\/acsnano.7b01809","volume":"11","author":"W Chen","year":"2017","unstructured":"Chen, W. et al. Long-acting release formulation of exendin-4 based on biomimetic mineralization for type 2 diabetes therapy. ACS Nano 11, 5062\u20135069 (2017).","journal-title":"ACS Nano"},{"key":"993_CR9","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1073\/pnas.1914813117","volume":"117","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Shape-preserving amorphous-to-crystalline transformation of CaCO3 revealed by in situ TEM. Proc. Natl Acad. Sci. USA 117, 3397\u20133404 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"993_CR10","doi-asserted-by":"publisher","first-page":"2106520","DOI":"10.1002\/adma.202106520","volume":"34","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Coordination polymer-coated CaCO3 reinforces radiotherapy by reprogramming the immunosuppressive metabolic microenvironment. Adv. Mater. 34, 2106520 (2022).","journal-title":"Adv. Mater."},{"key":"993_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s44222-022-00004-6","volume":"1","author":"Y Chao","year":"2023","unstructured":"Chao, Y. & Liu, Z. Biomaterials tools to modulate the tumour microenvironment in immunotherapy. Nat. Rev. Bioeng. 1, 125\u2013138 (2023).","journal-title":"Nat. Rev. Bioeng."},{"key":"993_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41586-019-1645-x","volume":"574","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. Crosslinking ionic oligomers as conformable precursors to calcium carbonate. Nature 574, 394\u2013398 (2019).","journal-title":"Nature"},{"key":"993_CR13","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1126\/science.abg1915","volume":"372","author":"Z Mu","year":"2021","unstructured":"Mu, Z. et al. Pressure-driven fusion of amorphous particles into integrated monoliths. Science 372, 1466\u20131470 (2021).","journal-title":"Science"},{"key":"993_CR14","doi-asserted-by":"publisher","first-page":"2308017","DOI":"10.1002\/adma.202308017","volume":"36","author":"Z Ma","year":"2024","unstructured":"Ma, Z. et al. High mechanical strength alloy-like minerals prepared by inorganic ionic co-cross-linking. Adv. Mater. 36, 2308017 (2024).","journal-title":"Adv. Mater."},{"key":"993_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","volume":"1","author":"J Deckers","year":"2023","unstructured":"Deckers, J. et al. Engineering cytokine therapeutics. Nat. Rev. Bioeng. 1, 286\u2013303 (2023).","journal-title":"Nat. Rev. Bioeng."},{"key":"993_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat1482","volume":"3","author":"AK Abbas","year":"2018","unstructured":"Abbas, A. K., Trotta, E., Simeonov, R. D., Marson, A. & Bluestone, J. A. Revisiting IL-2: biology and therapeutic prospects. Sci. Immunol. 3, eaat1482 (2018).","journal-title":"Sci. Immunol."},{"key":"993_CR17","doi-asserted-by":"publisher","first-page":"2209778","DOI":"10.1002\/adma.202209778","volume":"36","author":"J Han","year":"2024","unstructured":"Han, J. et al. Bioresponsive immunotherapeutic materials. Adv. Mater. 36, 2209778 (2024).","journal-title":"Adv. Mater."},{"key":"993_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper, D. J. & Balkwill, F. R. Harnessing cytokines and chemokines for cancer therapy. Nat. Rev. Clin. Oncol. 19, 237\u2013253 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"993_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","volume":"21","author":"D Briukhovetska","year":"2021","unstructured":"Briukhovetska, D. et al. Interleukins in cancer: from biology to therapy. Nat. Rev. Cancer 21, 481\u2013499 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"993_CR20","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1158\/1078-0432.CCR-22-1493","volume":"28","author":"AM Nash","year":"2022","unstructured":"Nash, A. M. et al. Activation of adaptive and innate immune cells via localized IL-2 cytokine factories eradicates mesothelioma tumors. Clin. Cancer Res. 28, 5121\u20135135 (2022).","journal-title":"Clin. Cancer Res."},{"key":"993_CR21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41551-021-00797-8","volume":"5","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells. Nat. Biomed. Eng. 5, 1288\u20131305 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"993_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","volume":"22","author":"R Hernandez","year":"2022","unstructured":"Hernandez, R., P\u00f5der, J., LaPorte, K. M. & Malek, T. R. Engineering IL-2 for immunotherapy of autoimmunity and cancer. Nat. Rev. Immunol. 22, 614\u2013628 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"993_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41551-021-00831-9","volume":"6","author":"Y Agarwal","year":"2022","unstructured":"Agarwal, Y. et al. Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity. Nat. Biomed. Eng. 6, 129\u2013143 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"993_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41586-018-0830-7","volume":"565","author":"D-A Silva","year":"2019","unstructured":"Silva, D.-A. et al. De novo design of potent and selective mimics of IL-2 and IL-15. Nature 565, 186\u2013191 (2019).","journal-title":"Nature"},{"key":"993_CR25","doi-asserted-by":"publisher","first-page":"eaba1624","DOI":"10.1126\/science.aba1624","volume":"378","author":"GM Allen","year":"2022","unstructured":"Allen, G. M. et al. Synthetic cytokine circuits that drive T cells into immune-excluded tumors. Science 378, eaba1624 (2022).","journal-title":"Science"},{"key":"993_CR26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41586-021-03861-0","volume":"597","author":"F Mo","year":"2021","unstructured":"Mo, F. et al. An engineered IL-2 partial agonist promotes CD8+ T cell stemness. Nature 597, 544\u2013548 (2021).","journal-title":"Nature"},{"key":"993_CR27","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1021\/acs.chemmater.0c00975","volume":"32","author":"H Du","year":"2020","unstructured":"Du, H. et al. Additives: Their influence on the humidity- and pressure-induced crystallization of amorphous CaCO3. Chem. Mater. 32, 4282\u20134291 (2020).","journal-title":"Chem. Mater."},{"key":"993_CR28","doi-asserted-by":"publisher","first-page":"30159","DOI":"10.1073\/pnas.2012025117","volume":"117","author":"C-Y Sun","year":"2020","unstructured":"Sun, C.-Y. et al. From particle attachment to space-filling coral skeletons. Proc. Natl Acad. Sci. USA 117, 30159\u201330170 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"993_CR29","doi-asserted-by":"publisher","first-page":"2000003","DOI":"10.1002\/adfm.202000003","volume":"30","author":"Z Zou","year":"2020","unstructured":"Zou, Z. et al. Additives control the stability of amorphous calcium carbonate via two different mechanisms: surface adsorption versus bulk incorporation. Adv. Funct. Mater. 30, 2000003 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"993_CR30","first-page":"341","volume":"7","author":"M Fosca","year":"2022","unstructured":"Fosca, M., Rau, J. V. & Uskokovi\u0107, V. Factors influencing the drug release from calcium phosphate cements. Bioact. Mater. 7, 341\u2013363 (2022).","journal-title":"Bioact. Mater."},{"key":"993_CR31","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.3390\/ijms22094708","volume":"22","author":"A Szewczyk","year":"2021","unstructured":"Szewczyk, A., Skwira, A., Konopacka, A., S\u0105dej, R. & Prokopowicz, M. Mesoporous silica-bioglass composite pellets as bone drug delivery system with mineralization potential. Int. J. Mol. Sci. 22, 4708 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"993_CR32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.powtec.2008.04.020","volume":"189","author":"IC Sinka","year":"2009","unstructured":"Sinka, I. C., Motazedian, F., Cocks, A. C. F. & Pitt, K. G. The effect of processing parameters on pharmaceutical tablet properties. Powder Technol. 189, 276\u2013284 (2009).","journal-title":"Powder Technol."},{"key":"993_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/jps.20262","volume":"94","author":"CK Tye","year":"2005","unstructured":"Tye, C. K., Sun, C. & Amidon, G. E. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. J. Pharm. Sci. 94, 465\u2013472 (2005).","journal-title":"J. Pharm. Sci."},{"key":"993_CR34","doi-asserted-by":"publisher","first-page":"105127","DOI":"10.1016\/j.isci.2022.105127","volume":"25","author":"N Kommineni","year":"2022","unstructured":"Kommineni, N., Butreddy, A., Sainaga Jyothi, V. G. S. & Angsantikul, P. Freeze-drying for the preservation of immunoengineering products. iScience 25, 105127 (2022).","journal-title":"iScience"},{"key":"993_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijpharm.2015.04.068","volume":"489","author":"K-E Peiponen","year":"2015","unstructured":"Peiponen, K.-E. et al. Estimation of Young\u2019s modulus of pharmaceutical tablet obtained by terahertz time-delay measurement. Int. J. Pharm. 489, 100\u2013105 (2015).","journal-title":"Int. J. Pharm."},{"key":"993_CR36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ijpharm.2017.11.066","volume":"536","author":"C Hare","year":"2018","unstructured":"Hare, C., Bonakdar, T., Ghadiri, M. & Strong, J. Impact breakage of pharmaceutical tablets. Int. J. Pharm. 536, 370\u2013376 (2018).","journal-title":"Int. J. Pharm."},{"key":"993_CR37","doi-asserted-by":"publisher","first-page":"22096","DOI":"10.1073\/pnas.0909040106","volume":"106","author":"J Tao","year":"2009","unstructured":"Tao, J., Zhou, D., Zhang, Z., Xu, X. & Tang, R. Magnesium-aspartate-based crystallization switch inspired from shell molt of crustacean. Proc. Natl Acad. Sci. USA 106, 22096\u201322101 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"993_CR38","doi-asserted-by":"publisher","first-page":"2205680","DOI":"10.1002\/adma.202205680","volume":"34","author":"C Dong","year":"2022","unstructured":"Dong, C. et al. A calcium fluoride nanozyme for ultrasound-amplified and Ca2+-overload-enhanced catalytic tumor nanotherapy. Adv. Mater. 34, 2205680 (2022).","journal-title":"Adv. Mater."},{"key":"993_CR39","doi-asserted-by":"publisher","first-page":"2350580","DOI":"10.1002\/eji.202350580","volume":"54","author":"C Sommer","year":"2024","unstructured":"Sommer, C. et al. Interleukin-2-induced skin inflammation. Eur. J. Immunol. 54, 2350580 (2024).","journal-title":"Eur. J. Immunol."},{"key":"993_CR40","doi-asserted-by":"publisher","first-page":"eabm1032","DOI":"10.1126\/sciadv.abm1032","volume":"8","author":"AM Nash","year":"2022","unstructured":"Nash, A. M. et al. Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors. Sci. Adv. 8, eabm1032 (2022).","journal-title":"Sci. Adv."},{"key":"993_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22674-3","volume":"12","author":"H Li","year":"2021","unstructured":"Li, H. et al. Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis. Nat. Commun. 12, 2773 (2021).","journal-title":"Nat. Commun."},{"key":"993_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","volume":"25","author":"MA Williams","year":"2007","unstructured":"Williams, M. A. & Bevan, M. J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25, 171\u2013192 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"993_CR43","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/eji.200637023","volume":"37","author":"MF Bachmann","year":"2007","unstructured":"Bachmann, M. F., Wolint, P., Walton, S., Schwarz, K. & Oxenius, A. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Eur. J. Immunol. 37, 1502\u20131512 (2007).","journal-title":"Eur. J. Immunol."},{"key":"993_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature04790","volume":"441","author":"MA Williams","year":"2006","unstructured":"Williams, M. A., Tyznik, A. J. & Bevan, M. J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441, 890\u2013893 (2006).","journal-title":"Nature"},{"key":"993_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","volume":"32","author":"ME Pipkin","year":"2010","unstructured":"Pipkin, M. E. et al. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32, 79\u201390 (2010).","journal-title":"Immunity"},{"key":"993_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","volume":"32","author":"V Kalia","year":"2010","unstructured":"Kalia, V. et al. Prolonged interleukin-2R\u03b1 expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32, 91\u2013103 (2010).","journal-title":"Immunity"},{"key":"993_CR47","doi-asserted-by":"publisher","first-page":"eaaw4744","DOI":"10.1126\/scitranslmed.aaw4744","volume":"12","author":"SK Eskandari","year":"2020","unstructured":"Eskandari, S. K. et al. Regulatory T cells engineered with TCR signaling\u2013responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter. Sci. Transl. Med. 12, eaaw4744 (2020).","journal-title":"Sci. Transl. Med."},{"key":"993_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jcp.2006.046201","volume":"61","author":"GM Tse","year":"2008","unstructured":"Tse, G. M., Tan, P.-H., Pang, A. L. M., Tang, A. P. Y. & Cheung, H. S. Calcification in breast lesions: pathologists\u2019 perspective. J. Clin. Pathol. 61, 145\u2013151 (2008).","journal-title":"J. Clin. Pathol."},{"key":"993_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/1817-1737.62469","volume":"5","author":"AN Khan","year":"2010","unstructured":"Khan, A. N. et al. The calcified lung nodule: what does it mean? Ann. Thorac. Med. 5, 67\u201379 (2010).","journal-title":"Ann. Thorac. Med."},{"key":"993_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11782-w","volume":"10","author":"Z Sun","year":"2019","unstructured":"Sun, Z. et al. A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control. Nat. Commun. 10, 3874 (2019).","journal-title":"Nat. Commun."},{"key":"993_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41586-022-05257-0","volume":"610","author":"M Hashimoto","year":"2022","unstructured":"Hashimoto, M. et al. PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program. Nature 610, 173\u2013181 (2022).","journal-title":"Nature"},{"key":"993_CR52","doi-asserted-by":"publisher","first-page":"eaan3682","DOI":"10.1126\/scitranslmed.aan3682","volume":"10","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. In situ formed reactive oxygen species\u2013responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy. Sci. Transl. Med. 10, eaan3682 (2018).","journal-title":"Sci. Transl. Med."},{"key":"993_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20220-1","volume":"11","author":"D Sahin","year":"2020","unstructured":"Sahin, D. et al. An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer. Nat. Commun. 11, 6440 (2020).","journal-title":"Nat. Commun."},{"key":"993_CR54","doi-asserted-by":"publisher","first-page":"367ra166","DOI":"10.1126\/scitranslmed.aag3187","volume":"8","author":"N Arenas-Ramirez","year":"2016","unstructured":"Arenas-Ramirez, N. et al. Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2. Sci. Transl. Med. 8, 367ra166 (2016).","journal-title":"Sci. Transl. Med."},{"key":"993_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s43018-022-00335-8","volume":"3","author":"SL Meier","year":"2022","unstructured":"Meier, S. L., Satpathy, A. T. & Wells, D. K. Bystander T cells in cancer immunology and therapy. Nat. Cancer 3, 143\u2013155 (2022).","journal-title":"Nat. Cancer"},{"key":"993_CR56","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor. Nat. Immunol. 22, 358\u2013369 (2021).","journal-title":"Nat. Immunol."},{"key":"993_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27390-6","volume":"13","author":"N Momin","year":"2022","unstructured":"Momin, N. et al. Maximizing response to intratumoral immunotherapy in mice by tuning local retention. Nat. Commun. 13, 109 (2022).","journal-title":"Nat. Commun."},{"key":"993_CR58","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41568-023-00628-9","volume":"23","author":"P Swietach","year":"2023","unstructured":"Swietach, P., Boedtkjer, E. & Pedersen, S. F. How protons pave the way to aggressive cancers. Nat. Rev. Cancer 23, 825\u2013841 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"993_CR59","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1245\/s10434-008-0048-2","volume":"15","author":"FJ Attenello","year":"2008","unstructured":"Attenello, F. J. et al. Use of Gliadel (BCNU) Wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann. Surg. Oncol. 15, 2887\u20132893 (2008).","journal-title":"Ann. Surg. Oncol."},{"key":"993_CR60","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1586\/14737140.2013.840090","volume":"13","author":"A Bregy","year":"2013","unstructured":"Bregy, A. et al. The role of Gliadel wafers in the treatment of high-grade gliomas. Expert Rev. Anticancer Ther. 13, 1453\u20131461 (2013).","journal-title":"Expert Rev. Anticancer Ther."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00993-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00993-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00993-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:41:48Z","timestamp":1757184108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-00993-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1038\/s43018-025-00993-4","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.G. is the co-founder of Zenomics Inc., Zcapsule Inc. and \u03bcZen Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}